European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

导出原文传递

翻译打印收藏纠错

作者： Babjuk M. ^[1] ; Burger M. ^[2] ; Capoun O. ^[3] ; Cohen D. ^[4] ; Comperat E.M. ^[5] ; Dominguez Escrig J.L. ^[6] ; Gontero P. ^[7] ; Liedberg F. ^[8] ; Masson-Lecomte A. ^[9] ; Mostafid A.H. ^[10] ; Palou J. ^[11] ; van Rhijn B.W.G. ^[12] ; Roupret M. ^[13] ; Shariat S.F. ; Seisen T. ; Soukup V. ; Sylvester R.J.

作者单位： Department of Urology The Stokes Centre for Urology Royal Surrey Hospital ^[1] Department of Urology Città della Salute e della Scienza University of Torino School of Medicine ^[2] Department of Urology Fundación Instituto Valenciano de Oncología ^[3] GRC 5 Predictive Onco-Uro Department of Urology Sorbonne University AP-HP Pitié Salpétrière Hospital ^[4] European Association of Urology ^[5] Department of Urology General Teaching Hospital and 1st Faculty of Medicine Charles University Praha ^[6] Department of Urology Fundacio Puigvert Universitat Autònoma de Barcelona ^[7] Department of Translational Medicine Lund University ^[8] Department of Urology Teaching Hospital Motol and 2nd Faculty of Medicine Charles University Praha ^[9] Department of Urology Caritas St. Josef Medical Center University of Regensburg ^[10] Department of Pathology Tenon Hospital AP-HP Sorbonne University ^[11] Department of Urology Royal Free London NHS Foundation Trust Royal Free Hospital ^[12] Department of Urology Université de Paris APHP Saint Louis Hospital ^[13]

关键词 Bacillus Calmette-Guerin (BCG)BCG unresponsive Bladder cancer Cystoscopy Diagnosis European Association of Urology (EAU)Follow-up Guidelines Intravesical chemotherapy Prognosis Radical cystectomy Transurethral resection (TUR)Urothelial carcinoma

发布时间 2022-03-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交